Patent ID: 11967399
Assignee: SHENZHEN NEOCURA BIOTECHNOLOGY CORPORATION
Field: Biotechnology (Chemistry)
Classification: CPC C  G | IPC C  G

Claim 1:
2. The method according to claim 1, wherein, step S1: processing the normal sample and the tumor sample, sequencing the specific region and detecting the somatic mutations in the patient, comprises:
step S101: performing a DNA sequencing on the normal tissue sample and the tumor tissue sample by a whole-exome sequencing (WES) method or a specific-region panel sequencing method to obtain sequencing data, and performing an alignment on the sequencing data to obtain a genome of the normal sample and a genome of the tumor sample; and
step S102: obtaining the somatic mutations in the specific region from the genome of the normal tissue sample and the genome of the tumor tissue sample.